Cargando…

Gain-of-Function Polymorphisms in Human Inflammasomes: Implications for Cystic Fibrosis

Detalles Bibliográficos
Autores principales:	Jeansonne, Duane, Jeyaseelan, Samithamby
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Thoracic Society 2021
Materias:	Editorials
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8399577/ https://www.ncbi.nlm.nih.gov/pubmed/34033526 http://dx.doi.org/10.1165/rcmb.2021-0183ED

Ejemplares similares

Kill Two Birds with One Stone: Role of the RIPK-3 in Necroptosis and Inflammasome Activation
por: Paudel, Sagar, et al.
Publicado: (2021)

Regulation of emergency granulopoiesis during infection
por: Paudel, Sagar, et al.
Publicado: (2022)

Kiss of Death: Ring Finger 216 Regulates Toll-like Receptor 8 Stability through Ubiquitination
por: Ghimire, Laxman, et al.
Publicado: (2020)

Epithelial STAT3: A New Twist in Inducible Antimicrobial Resistance
por: Le, John, et al.
Publicado: (2023)

Cystic Fibrosis Lung Disease and Immunometabolism. Targeting the NLRP3 Inflammasome
por: Cantin, André M.
Publicado: (2019)

Inflammasome-Mediated IL-1β Production in Humans with Cystic Fibrosis
por: Tang, Anthony, et al.
Publicado: (2012)

Cystic fibrosis revisited
por: Kulkarni, H, et al.
Publicado: (2019)

Early Antibiotics in Cystic Fibrosis: Lessons from the Cystic Fibrosis Pig Model
por: Lu, Shiping, et al.
Publicado: (2021)

Cystic Fibrosis Screen Positive, Inconclusive Diagnosis Genotypes in the Cystic Fibrosis Registry
por: Thompson, Cassandra, et al.
Publicado: (2023)

Diminished neutrophil extracellular trap (NET) formation is a novel innate immune deficiency induced by acute ethanol exposure in polymicrobial sepsis, which can be rescued by CXCL1
por: Jin, Liliang, et al.
Publicado: (2017)

Role of toll-like receptors and nod-like receptors in acute lung infection
por: Le, John, et al.
Publicado: (2023)

Clinical Advances in Cystic Fibrosis
por: Imperlini, Esther, et al.
Publicado: (2022)

Cystic Fibrosis: “Ionocyte Modulators”?
por: Shah, Viral S., et al.
Publicado: (2023)

The treatment burden of cystic fibrosis: a day-to-day experience with treatment as someone with cystic fibrosis
por: Maetz, Jessica, et al.
Publicado: (2021)

A New Era for Cystic Fibrosis and Cystic Fibrosis Transmembrane Conductance Regulator Modulator Trials in Infants
por: Wainwright, Claire E.
Publicado: (2022)

Unraveling the CFTR Function–Phenotype Connection for Precision Treatment in Cystic Fibrosis
por: Zemanick, Edith T., et al.
Publicado: (2019)

Cystic fibrosis in Brazil: achievements in survival
por: Vendrusculo, Fernanda Maria, et al.
Publicado: (2021)

The Impact of COVID-19 in Cystic Fibrosis
por: Flume, Patrick A., et al.
Publicado: (2022)

Evidence for Early Cystic Fibrosis Transmembrane Conductance Regulator Modulator Treatment for Children with Cystic Fibrosis Keeps Growing
por: Hoppe, Jordana E., et al.
Publicado: (2022)

IL-1 receptor antagonist ameliorates inflammasome-dependent inflammation in murine and human cystic fibrosis
por: Iannitti, Rossana G., et al.
Publicado: (2016)

Where Is the Cystic Fibrosis Transmembrane Conductance Regulator?
por: Barbry, Pascal, et al.
Publicado: (2021)

Dornase alpha use in patients with cystic fibrosis
por: Marostica, Paulo José C.
Publicado: (2013)

New Developments in Cystic Fibrosis Airway Inflammation
por: Palaniyar, Nades, et al.
Publicado: (2015)

Ciprofloxacin dry powder inhaler in cystic fibrosis
por: Elborn, J Stuart
Publicado: (2016)

Comparing cystic fibrosis outcomes across the pond
por: Taylor-Robinson, David C, et al.
Publicado: (2015)

Steps toward Cell Therapy for Cystic Fibrosis
por: Koh, Kyung Duk, et al.
Publicado: (2020)

Cystic fibrosis-related diabetes: The unmet need
por: Pozo, Leonardo, et al.
Publicado: (2020)

Preclinical Modeling for Therapeutic Development in Cystic Fibrosis
por: Bonfield, Tracey L.
Publicado: (2020)

Cystic Fibrosis Inflammation: Hyperinflammatory, Hypoinflammatory, or Both?
por: Murphy, Sean V., et al.
Publicado: (2019)

NLRP6 negatively regulates pulmonary host defense in Gram-positive bacterial infection through modulating neutrophil recruitment and function
por: Ghimire, Laxman, et al.
Publicado: (2018)

NLRP12 Modulates Host Defense through IL-17A-CXCL1 Axis
por: Cai, Shanshan, et al.
Publicado: (2015)

Falling through the Cracks—The Impact of Care Gaps on Lung Function Loss in Cystic Fibrosis
por: Love, Allison J., et al.
Publicado: (2023)

Early Glucose Abnormalities in Cystic Fibrosis Are Preceded by Poor Weight Gain
por: Hameed, Shihab, et al.
Publicado: (2010)

COVID-19: Pathophysiology and implications for cystic fibrosis, diabetes and cystic fibrosis-related diabetes
por: Mason, Kelly, et al.
Publicado: (2021)

The Future of Highly Effective Modulator Therapy in Cystic Fibrosis
por: Daines, Cori L., et al.
Publicado: (2021)

Nutrition in Cystic Fibrosis: as important as the management of pulmonary disease
por: Adde, Fabíola Villac
Publicado: (2015)

Airway Inflammatory/Immune Responses in COPD and Cystic Fibrosis
por: De Rose, Virginia, et al.
Publicado: (2018)

Shifting Landscape of Airway Infection in Early Cystic Fibrosis
por: Hoppe, Jordana E., et al.
Publicado: (2019)

Editorial: Special Issue on “Therapeutic Approaches for Cystic Fibrosis”
por: Pedemonte, Nicoletta
Publicado: (2020)

Is PI3K a Villain in Cystic Fibrosis?
por: Natarajan, Viswanathan
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_dmpiif9kqo8s9mibtgppds4evb